Summary:
In children and adolescents with suboptimally controlled type 1 diabetes using CGM and multiple daily insulin injections, intensified follow-up with weekly telehealth intervention significantly improved glycemic control, including reductions in HbA1c levels and improvements in CGM metrics compared to routine care without intensified telehealth, though it was associated with no significant adverse effects and did not alter time below range (TBR).
| PICO | Description |
|---|---|
| Population | Children and adolescents (mean age 11.8 years) with type 1 diabetes of approximately 3.5 years duration, using FreeStyle Libre 2 CGM and multiple daily insulin injections. Participants had suboptimal glycemic control (mean HbA1c 9.4%). |
| Intervention | Weekly intensive telehealth support for 12 weeks, including 20-minute phone consultations and digital education led by a trained diabetes educator, with structured review of CGM data. |
| Comparison | Routine diabetes care without additional telehealth intervention, administered over a comparable 12-week period; participants served as their own control in a two-period crossover design. |
| Outcome | The telehealth intervention resulted in a statistically significant reduction in HbA1c (-0.29%, 95% CI: -0.41 to -0.17; p < 0.001), increased time in range (TIR), decreased time above range (TAR), and reductions in average glucose, glucose variability, glucose management indicator (GMI), and low glucose event frequency. Time below range (TBR) remained within target and unchanged. |
Source: Asma Deeb, et al. “Effect of an Intensive, Integrated Telehealth Intervention on Glycemic Control in Children and Adolescents With Type 1 Diabetes Using Continuous Glucose Monitoring: A Randomized, Crossover Trial.” Read article here.
